Improved treatment outcome of MDR-TB in Eastern Taiwan: Reducing default rate by DOTS Plus

被引：0
|
作者：
Lin, Chih Bin [1 ,2 ]
Lee, Jen-Jyh [1 ,2 ]
Sun, Hung-Chieh [3 ]
机构：
[1] Tzu Chi Gen Hosp, Internal Med, Hualien 970, Taiwan
[2] Tzu Chi Univ, Hualien 970, Taiwan
[3] Mennonite Christian Hosp, Internal Med, Hualien 970, Taiwan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷
关键词：
MDR-TB; Tuberculosis; -; management;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3670
引用
收藏
页数：1
相关论文
共 37 条
  • [1] Rational 'DOTS Plus' for the control of MDR-TB
    Espinal, MA
    Dye, C
    Raviglione, M
    Kochi, A
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1999, 3 (07) : 561 - 563
  • [2] Impact of prompt MDR-TB treatment initiation: significant reduction of MDR-TB mortality rate in Rwanda
    Ngabonziza, J. C. S.
    Habimana, M. Y.
    Migambi, P.
    Mazarati, J. B.
    de Jong, B. C.
    Torrea, G.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2017, 22 : 214 - 215
  • [3] Clinical management improves the treatment outcome of MDR-TB patients
    Chen, Ling
    Liu, Quanxian
    Li, Yuqin
    Zhang, Jianyong
    Zhang, Hong
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [4] Study of Adverse Drug Reactions and Treatment Outcome in Mdr-Tb Patients Registered at Dots Plus Site, Ssg Hospital, Baroda, Gujarat
    Vithalapara, K. V.
    Trivedi, N. A.
    Makwana, M. Z.
    Patel, K. R.
    Leuva, A. T.
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 : S21 - S22
  • [5] Clinical profile of MDR-TB patients and their early response to DOTS PLUS: An Indian perspective
    Javia, Abhay
    Mehta, Deval
    Ganchi, Firoz
    Rathod, Bhupandra
    Chopada, Kalpesh
    Bhanderi, Milan
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [6] Could side effects of MDR-TB treatment change the outcome of the disease?
    Snene, Houda
    Daghfous, Hafaoua
    Ben Saad, Soumaya
    Ben Khelifa, Mouna
    Belhadj, Sameh
    Slim, Leila
    Tritar, Fatma
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [7] A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB)
    Gupta, R
    Espinal, M
    Beggs, A
    Laing, R
    Preger, J
    Castro, K
    Cegielski, JP
    De Luca, N
    Laserson, K
    Walton, W
    Wells, C
    Erokhin, V
    Mishin, V
    Vassilieva, I
    Karataev, ON
    Drobniewski, F
    Brander, L
    Katila, ML
    Malakhov, I
    Safonova, S
    Sheyanenko, O
    Starchenkova, N
    Farmer, P
    Hiatt, H
    Kim, J
    Mukherjee, J
    Murray, M
    Becerra, M
    Nardell, E
    Palmero, DJ
    Bonilla, C
    Solovic, I
    Mahmud, AM
    Rahman, A
    Melnyk, VM
    Portaels, F
    Creach, P
    Billo, N
    Repina, E
    Rakhishev, G
    Pechiorina, I
    Squire, SB
    Coker, R
    Arora, VK
    Sloutsky, A
    Timperi, R
    Henkens, M
    Lafontaine, D
    Slavuckij, A
    Vezhnina, N
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2003, 7 (05) : 410 - 414
  • [8] MDR-TB and the developing world - a problem no longer to be ignored: the WHO announces 'DOTS Plus' strategy
    Iseman, MD
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1998, 2 (11) : 867 - 867
  • [9] Long Term Treatment Outcome in Multi Drug Resistant Tuberculosis (MDR-TB)
    Prasad, R.
    Verma, S. K.
    Verma, S. K.
    Jain, A.
    Ahuja, R. C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [10] Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India
    Joseph, Pauline
    Desai, Vijaya Bhaskara Rao
    Mohan, Nalini Sunder
    Fredrick, Jemima Sheila
    Ramachandran, Rajeswari
    Raman, Balambal
    Wares, Fraser
    Ramachandran, Ranjani
    Thomas, Aleyamma
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2011, 133 (05) : 529 - 534
1234